Therapeutically active 17-nitrogen substituted estratrienthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase

• 收藏
• 分享

专利权人:

フォレンド ファーマ リミテッド

发明人:

エロランタ，メール,ヒルベラ，リーナ,カンガス，ラウリ,コスキミエス，パシ,ラミンタウスタ，リスト,ウンキラ，ミッコ

申请号：

JP2016522679

公开号：

JP6556125B2

申请日:

2014.06.25

申请国别(地区):

JP

年份:

2019

代理人:

摘要：

The invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof wherein R2 to R7 are as defined in the claims. The invention further relates to their use as inhibitors of 17β-HSD and in treatment or prevention of steroid hormone de-pendent diseases or disorders, such as steroid hormone dependent diseases or disorders requiring the inhibition of the 17β-HSD1 enzyme and/or requiring the lowering of the endogenous estradiol concentration. The present invention also relates to the preparation of the aforementioned compounds and to pharmaceutical compositions comprising as an active ingredient(s) one or more of the afore-mentioned compounds or pharmaceutically acceptable salts thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/